Breaking

Novo Nordisk, the pharmaceutical company, has requested the Food and Drug Administration (FDA) to stop compounding pharmacies from producing generic versions of its popular weight loss drug semaglutide. The company believes that the medication...

Today, we're diving into the latest healthcare and policy news, straight from D.C. Diagnosis, STAT's newsletter. As we navigate through a tumultuous election season, it's always nice to find some solace in shows like...

Senators, including Sen. Dick Durbin, are calling on Pfizer and Eli Lilly to provide more information about their partnerships with telehealth providers. These pharmaceutical companies recently launched websites that offer users information about their...

During the final stretch of the 2024 campaign, pharmaceutical company executives have not been very active in donating directly to political candidates. However, those who did donate mostly chose to support Democratic candidates. Out...

Scientific experts working on the development of the 2025-2030 Dietary Guidelines for Americans recently discussed the challenges of including ultra-processed foods due to a lack of a clear definition and limited scientific research on...

Kamala Harris recently shared some of her medical information and urged Donald Trump to do the same, sparking a debate about whether presidential candidates should be required to disclose their medical records. However, George...

Catalent, a major contract drug manufacturer, recently reassured its customers through an open letter that its proposed acquisition by Novo Nordisk’s parent company for $16.5 billion would not impact its ability to provide services...

Seaport Therapeutics, a new biotech startup led by the team from Karuna Therapeutics, has successfully secured an additional $225 million in funding just half a year after its last fundraising effort. The Series B...

D.A. Wallach shared a deeply personal story at the 2024 STAT Summit in Boston, revealing how the tragic loss of his wife inspired him to advocate for change in the U.S. health system. He...

Pascal Geldsetzer, an epidemiologist from Stanford University, recently conducted a groundbreaking study that explores the potential link between chickenpox, shingles, and Alzheimer's disease. Despite his belief in open access to scientific information, Geldsetzer hesitated...

Amgen, Biogen, and Takeda are three biopharma companies facing challenges in developing treatments for obesity and Alzheimer's disease. At the STAT 2024 Summit in Boston, leaders from these companies discussed their research and development...

Alnylam Pharmaceuticals, led by CEO Yvonne Greenstreet, is making strides in expanding the use of its RNA-based gene-silencing heart drug, vutrisiran. The drug has shown promising results in reducing the risk of death and...